ClinicalTrials.gov
ClinicalTrials.gov Menu

Montelukast Post-Marketing Comparative Study With Ketotifen (0476-379)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00446056
Recruitment Status : Completed
First Posted : March 12, 2007
Last Update Posted : September 15, 2017
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 16, 2004
  Actual Study Completion Date : June 16, 2004
Publications of Results:
Sankei N, Kenshi F, Susumu F, Shigemi Y. Cysteinyl leukotriene receptor 1 antagonist; monterukast on childhood bronchial asthma in multicenter comparative double-blind study (Phase IV) with ketotifen fumarate. J Clin Therapeut Med. 2005;21(6):605-636